**Core Concept:** Hormone Replacement Therapy (HRT) is a medical treatment involving administration of hormones to replace those that are deficient or not produced adequately in the body. In postmenopausal women, HRT aims to alleviate menopausal symptoms such as hot flushes, night sweats, vaginal dryness, and mood swings.

**Why the Correct Answer is Right:** HRT is beneficial for addressing menopausal symptoms, but it may not be suitable for all patients. In this question, we are discussing oral estrogen and progestogen therapy, which carries a higher risk of venous thromboembolism (VTE) compared to other forms of HRT like transdermal estrogen or combined oral estrogen and progestogen with a selective serotonin reuptake inhibitor (SSRI).

**Why Each Wrong Option is Incorrect:**

**Option A:** Oral estrogen therapy alone is associated with a higher risk of VTE due to increased blood clot formation.

**Option B:** Transdermal estrogen therapy, while reducing the risk of VTE, still has benefits in treating menopausal symptoms and is suitable for some patients.

**Option C:** Combined oral estrogen and progestogen therapy with an SSRI reduces the risk of VTE compared to oral combination with progestogen alone.

**Option D:** HRT generally improves bone density and reduces the risk of osteoporosis, but this option specifically refers to the risk of VTE.

**Clinical Pearl:** When considering HRT, consider patient-specific risk factors for VTE (e.g., obesity, smoking, immobility) and discuss the risk-benefit ratio with the patient. Choose the most appropriate HRT regimen based on individual risk factors and patient preferences.

**Correct Answer:** D. Transdermal estrogen and combined oral estrogen and progestogen therapy with an SSRI reduce the risk of venous thromboembolism (VTE) compared to oral estrogen and progestogen therapy. In this question, we are focusing on the risk of VTE and not discussing the benefits of HRT for treating menopausal symptoms or reducing the risk of osteoporosis.